Products for Research Use Only
RegisterLogin

EHNA

CAT: 0804-HY-103160BSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103160BSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EHNA is a potent and selective dual inhibitor of cyclic nucleotide phosphodiesterase 2 (PDE2) (IC50=4 μM) and adenosine deaminase (ADA) . EHNA exerts a concentration inhibition of the cGMP-stimulated PDE II (cGs-PDE) (IC50:0.8 μM (human), 2 μM (porcine myocardium) ), but has smaller inhibitory effect on the unstimulated PDE2 activity. EHNA play roles in mediating diverse pharmacological responses, including antiviral, antitumour and antiarrhythmic effects[1][2][3].
CAS Number
51350-19-7
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Adenosine Deaminase; Influenza Virus; Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ehna.html
Smiles
CCCCCC[C@@](N1C2=C(C(N)=NC=N2)N=C1)([H])[C@H](O)C
Molecular Formula
C14H23N5O
Molecular Weight
277.37
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Podzuweit T, et al. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9- (2-hydroxy-3-nonyl) adenine.Cell Signal. 1995 Sep;7 (7) :733-8.|[2]Michie AM, et al. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9- (2-hydroxy-3-nonyl) -adenine (EHNA) and rolipram.Cell Signal. 1996 Feb;8 (2) :97-110.|[3]Blázquez-Bermejo C, et al. Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts. FASEB J. 2019 Jun;33 (6) :7168-7179.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
T203253-01EHNA
bs-82492C-01EHNA HCl
sc-201184AEHNA hydrochloride
A21585-10EHNA hydrochloride 10mg
A21585-50EHNA hydrochloride 50mg
A21585-5EHNA hydrochloride 5mg
A21585-2EHNA hydrochloride 2mg
TBI2438-50MGEHNA Hydrochloride, PDE2 and ADA Inhibitor

Popular Products